Magrolimab
Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits antitumor activity by blocking CD47 and binding primarily to the N-terminal pyroglutamate of CD47. It can be used in combination with other compounds for the treatment of recurrent myeloma.
Product Specifications
CAS Number
2169232-81-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1307741-01 0.02 mg (E-Coli)
Recombinant Streptomyces coelicolor Small neutral protease regulatory protein (mprR)
Sign In for Pricing
View Details MBS1307741-02 0.02 mg (Yeast)
Recombinant Streptomyces coelicolor Small neutral protease regulatory protein (mprR)
Sign In for Pricing
View Details MBS1307741-03 0.1 mg (E-Coli)
Recombinant Streptomyces coelicolor Small neutral protease regulatory protein (mprR)
Sign In for Pricing
View Details MBS1307741-04 0.1 mg (Yeast)
Recombinant Streptomyces coelicolor Small neutral protease regulatory protein (mprR)
Sign In for Pricing
View Details MBS1307741-05 0.02 mg (Baculovirus)
Recombinant Streptomyces coelicolor Small neutral protease regulatory protein (mprR)
Sign In for Pricing
View Details MBS1307741-06 0.02 mg (Mammalian-Cell)
Recombinant Streptomyces coelicolor Small neutral protease regulatory protein (mprR)
Sign In for Pricing
View Details